Study Identifies a New Test to Predict Severity of Inflammatory Bowel Disease in Children

Gastroenterology May 14, 2017 at 8:30 AM 0 comments

Prague, 13 May, 2017 – The results from a Norwegian study show that a new genetic test for characterising intestinal microbiota may help to diagnose inflammatory bowel disease (IBD) in children and predict which children will develop the most extensive disease and need early, aggressive intervention. Researchers from Oslo, NorwayRead More

NeuroDigm Uses Tissue Repair in an Innovative Nerve Pain Model

Neurology May 12, 2017 at 10:39 AM 0 comments

NeuroDigm President speaks on a gentle pain model in London May 22. Colorado, USA, May 12, 2017 – NeuroDigm, dedicated to translating clinical knowledge into a new platform for research and development focused on neural pain, today announced that Mary Hannaman MD, president, will speak at Seligman Medical Institute’s (SMI) 17thRead More

University Research Opens Door to U.S. Market for UK Chemotherapy Scalp Cooling Firm

University Research Opens Door to U.S. Market for UK Chemotherapy Scalp Cooling Firm

Oncology May 11, 2017 at 9:13 AM 0 comments

University of Huddersfield researchers’ breakthroughs on the Paxman Scalp Cooling System has led to the UK company receiving the go-ahead to enter the American market. Huddersfield, UK, 10 May, 2017 – A pioneering UK company that produces technology designed to reduce hair loss during cancer treatment has been given official clearanceRead More

Consilium Strategic Communications Strengthens Senior International Healthcare Team with the Appointment of Philippa Gardner and Suki Virji

Uncategorized May 9, 2017 at 2:04 PM 0 comments

London, UK, 8 May, 2017 – Consilium Strategic Communications, a global leader in strategic healthcare communications, today announces the appointment of Philippa Gardner and Suki Virji to the London office. Philippa has more than 13 years’ experience as a healthcare sell-side analyst covering European biotechnology, life sciences and mid-cap pharma companiesRead More

Introducing EMJ Urology 5.1

Introducing EMJ Urology 5.1

Urology May 9, 2017 at 9:42 AM 0 comments

United Kingdom, May 09, 2017: Welcome to the newest edition of our EMJ Urology eJournal, packed with the latest urological developments. This issue is jam-packed with interviews, abstracts, and peer-reviewed papers covering a wide range of topics and research. Highlights from the European Association of Urology (EAU) Congress 2017 areRead More

Relvar Ellipta Significantly Improved Asthma Control in Salford Lung Study Patients Compared with Their Usual Care

Respiratory May 5, 2017 at 5:04 PM 0 comments

Primary endpoint showed patients initiated with Relvar Ellipta had twice the odds of achieving an improvement in asthma control compared with patients continuing usual care. GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva Inc (NASDAQ: INVA) today announced positive results from the innovative Salford Lung Study (SLS) in asthma, carried out amongstRead More

Osimertinib Improves Symptoms in Advanced Lung Cancer Patients

Oncology, Respiratory May 5, 2017 at 4:56 PM 0 comments

Geneva, Switzerland, 05 May, 2017 – Osimertinib improves cancer-related symptoms in patients with advanced lung cancer, according to an analysis of patient-reported outcomes from the AURA3 phase III clinical trial presented today at the European Lung Cancer Conference (ELCC). “I often see new treatments that might be more effective, butRead More

White Blood Cell Count Predicts Response to Lung Cancer Immunotherapy

Respiratory May 5, 2017 at 9:07 AM 0 comments

Geneva, Switzerland, 05 May 2017 – White blood cell counts can predict whether or not lung cancer patients will benefit from immunotherapy, according to research presented at the European Lung Cancer Conference (ELCC). “Immune checkpoint inhibitors such as nivolumab and pembrolizumab significantly improve overall survival in some – but notRead More

AlzProtect : The American Food and Drug Administration (FDA) Has Granted AZP2006 the Orphan Drug Designation for the Treatment of Progressive Supranuclear Palsy (PSP)

Neurology May 4, 2017 at 1:58 PM 0 comments

The drug candidate AZP2006 has an original mechanism of action and aims to treat several neurodegenerative pathologies for which there is no treatment: Tauopathies including Alzheimer’s disease and Progressive Supranuclear Palsy (PSP). Lille, France 04 May, 2017 – AlzProtect, a biopharmaceutical company committed to the development of drugs for theRead More

Hookipa Biotech Presents Positive Data from Phase 1 First-In-Human Trial of Vaccine Against Cytomegalovirus

Uncategorized May 4, 2017 at 1:55 PM 0 comments

Vaccine was safe and elicited a potent immune response Cytomegalovirus (CMV) infection is the leading cause of  birth defects in the developed world, occurring in 1 – 2.5 % of all newborns and conferring risk of deafness and impaired intellectual development Vienna, Austria, 04 May, 2017 – Hookipa Biotech AG,Read More